SANCILIO PHARMACEUTICALS COMPANY, INC. [●] Shares Common Stock ($[●] par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • December 30th, 2015 • Sancilio Pharmaceuticals Company, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 30th, 2015 Company Industry Jurisdiction
FORM OF INDEMNIFICATION AGREEMENTForm of Indemnification Agreement • December 30th, 2015 • Sancilio Pharmaceuticals Company, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 30th, 2015 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20 between Sancilio Pharmaceuticals Company, Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
SUMMARY OF AGREEMENT OF LEASE FOR SIGNATURE INDUSTRIAL CENTERSummary of Agreement • December 30th, 2015 • Sancilio Pharmaceuticals Company, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledDecember 30th, 2015 Company Industry JurisdictionTHIS LEASE is made as of the 10th day of August 2015 between Mitzvah Enterprises, Inc., a Florida corporation and Paramus Associates, Inc., a Florida corporation, d/b/a Mitzvah Associates, J.V., with its offices at 6761 W. Indiantown Road Suite 29, Jupiter, Florida 33458, as Lessor, and Sancilio and Company, Inc., a Florida Corporation, with its offices at 3874 Fiscal Court, Suite 200, Riviera Beach, FL 33404 as Lessee.
TherapeuticsMD™Sancilio Pharmaceuticals Company, Inc. • December 30th, 2015 • Pharmaceutical preparations
Company FiledDecember 30th, 2015 IndustryThis letter confirms the mutual agreement of TherapeuticsMD, Inc. (“TXMD”) and Sancilio & Company, Inc. (“SCI”) (sometimes referred to as the “Parties” and each a “Party”), to extend the Term of the Master Services Agreement between the Parties entered into as of as of January 30, 2015 (the “MSA”) for six (6) months.